Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615774-15-001396
Filing Date
2015-06-08
Accepted
2015-06-08 11:14:45
Documents
1
Period of Report
2015-04-30

Document Format Files

Seq Description Document Type Size
1 3 s101143_form3.html 3  
1 3 s101143_form3.xml 3 1795
  Complete submission text file 0001615774-15-001396.txt   3340
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Issuer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address FRUEBJERGVEJ 3 BOX 62 COPENHAGEN G7 2100
Business Address
Degn Lone (Reporting) CIK: 0001643314 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54478 | Film No.: 15917763